CLINICAL TRIALS PROFILE FOR BETAMETHASONE DIPROPIONATE; CLOTRIMAZOLE

All Clinical Trials for betamethasone dipropionate; clotrimazole

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02582177 ↗	Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis	Completed	Ache Laboratorios Farmaceuticos S.A.	Phase 3	2019-06-11	To evaluate the no-inferiority of the ketoconazole20mg/g and betamethasone dipropionate 0.64 mg/g association (Candicort®) cream versus clotrimazole 10mg and dexamethasone acetate 0.443 mg/g association (Baycuten N®) cream, general relief of signs and symptoms (erythema, maceration, peeling, blistering / papules / pustules, itching and burning / stinging) 06 (± 1) days after onset treatment.

Clinical Trial Conditions for betamethasone dipropionate; clotrimazole

Condition Name

Condition Name for betamethasone dipropionate; clotrimazole
Intervention	Trials
Tinea	1

Condition MeSH

Condition MeSH for betamethasone dipropionate; clotrimazole
Intervention	Trials
Mycoses	1
Infections	1
Infection	1
Tinea	1

Clinical Trial Locations for betamethasone dipropionate; clotrimazole

Trials by Country

Trials by Country for betamethasone dipropionate; clotrimazole
Location	Trials
Brazil	4

Clinical Trial Progress for betamethasone dipropionate; clotrimazole

Clinical Trial Phase

Clinical Trial Phase for betamethasone dipropionate; clotrimazole
Clinical Trial Phase	Trials
Phase 3	1

Clinical Trial Status

Clinical Trial Status for betamethasone dipropionate; clotrimazole
Clinical Trial Phase	Trials
Completed	1

Clinical Trial Sponsors for betamethasone dipropionate; clotrimazole

Sponsor Name

Sponsor Name for betamethasone dipropionate; clotrimazole
Sponsor	Trials
Ache Laboratorios Farmaceuticos S.A.	1

Sponsor Type

Sponsor Type for betamethasone dipropionate; clotrimazole
Sponsor	Trials
Industry	1

Betamethasone dipropionate; clotrimazole Market Analysis and Financial Projection

Last updated: May 4, 2026

BETAMETHASONE DIPROPIONATE + CLOTRIMAZOLE: Clinical Trials Update, Market Analysis, and Projection

What clinical trials data is available for betamethasone dipropionate + clotrimazole?

No complete, current, drug-specific clinical trial update can be produced from the information available in this session.

What is the current market structure for betamethasone dipropionate + clotrimazole?

No complete, current market dataset can be produced from the information available in this session.

How should the market be projected for betamethasone dipropionate + clotrimazole?

No market projection can be produced from the information available in this session.

---

Key Takeaways

• A drug-specific clinical trials update is not deliverable from the information available in this session.
• A market analysis and numeric projection are not deliverable from the information available in this session.
• No evidence-backed tables, timelines, or forecasts are included.

---

FAQs

1. Is there a standardized global clinical-trials pipeline for this combination that can be summarized now?
   Not with the information available in this session.

2. What geographies and dosage forms dominate sales of betamethasone dipropionate + clotrimazole?
   Not with the information available in this session.

3. Is the combination protected by meaningful patent cover in key markets?
   Not with the information available in this session.

4. Do clinical outcomes differ materially versus single-ingredient comparators?
   Not with the information available in this session.

5. What forecast horizon and methodology should be used for a market projection?
   Not with the information available in this session.

---

References

No sources were provided in this session.